VEGFA and venous thromboembolism: However, despite the successes of antiangiogenic treatment via VEGF blockade, side effects as hemorrhage, venous thromboembolism, vascular regression with subsequent increase in metastasis incidence, adaptive resistance and limiting normal tissue toxicities on the clinical level, ask for new treatment combinations exploiting the rationale for combining radiotherapy with antiangiogenic agents (43–47).